UroToday.com – Men with low-risk prostate cancer (CaP) who are candidates for active surveillance (AS) often choose definitive therapy due to anxiety over their untreated cancer. In the September 1, 2009 issue of Cancer, a group of researchers from the Netherlands assessed anxiety and distress during AS for CaP.